Literature DB >> 9629478

Pharmacological properties of ACh receptors on the heart of the marine bivalve Meretrix lusoria.

C M Lee1, J T Lin, J C Hwang.   

Abstract

The cholinergic receptors on the heart of the marine bivalve Meretrix lusoria were used as a model to investigate their pharmacological properties in bivalves. By recording method, we measured the contractile force (CF) and the heart rate (HR) of the heart to examine the characteristics of cholinergic receptors of a marine bivalve. The known ACh receptor agonists or antagonists in vertebrate nervous system were then introduced into the heart by perfusion, to monitor their effects upon heart activities. Of the six tested agonists, two mAChR agonists (OXA-22, bethanechol) and two nAChR agonists (methylcarbachol, nicotine) mimicked the response induced by ACh. Among the seven tested antagonists, three mAChR antagonists (trihexyphenidy1, atropine and scopolamine) and three nAChR antagonists (TEA, curare and hexamethonium bromide) showed the antagonistic effects on the inhibition induced by ACh. However, there was one mAChR agonist, metoclopramide, that behaved like an ACh antagonist. Both APE (mAChR agonist) and PTMA (nAChR antagonist) showed no significant effects. This differences suggest that the pharmacological characteristics of ACh receptors on the heart of bivalve are different from those in vertebrates. It may be a novel type of ACh receptors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9629478

Source DB:  PubMed          Journal:  Chin J Physiol        ISSN: 0304-4920            Impact factor:   1.764


  2 in total

1.  Quantitative characteristics of negative inotropic effect of acetylcholine on the heart of the snail Helix pomatia.

Authors:  I V Suslova; V G Solomonova; O P Yurchenko; T M Turpaev
Journal:  Dokl Biol Sci       Date:  2005 Sep-Oct

2.  Norlaudanosoline and nicotine increase endogenous ganglionic morphine levels: nicotine addiction.

Authors:  Wei Zhu; Kirk J Mantione; Lihua Shen; Brian Lee; George B Stefano
Journal:  Cell Mol Neurobiol       Date:  2006-04-28       Impact factor: 5.046

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.